Exploring the critical roles of dopamine and norepinephrine in depression, their symptoms, and targeted treatments beyond traditional serotonin-focused approaches.
Discover how the depressed brain shows increased activation of anterior paralimbic and executive regions from waking to REM sleep and what this means for understanding depression.
Explore how early stress physically changes brain architecture and increases vulnerability to depression through neurobiological mechanisms.
Discover how patients, families, and doctors collaboratively define recovery from depression through a groundbreaking concept mapping study.
Exploring how inflammation fuels treatment-resistant depression and how monoclonal antibodies could revolutionize treatment.